Add this topic to your myFT Digest for news straight to your inbox
Deal with private equity-owned group would delist the coffee and doughnuts chain
Higher threshold for reporting stock holdings would benefit activist investors, US markets regulator told
All-stock deal for Parsley Energy would create $10bn company as sector consolidation gathers pace
Detroit carmaker is in negotiations to take 11 per cent stake in embattled start-up
John Henry’s Fenway Sports Group in talks to merge with blank-cheque company at $8bn valuation
Major hydrogen showcase is part of offensive following fraud allegations
Activist investor calls for radical shift of focus from box office to Disney+ arm
Google-backed insurer to go public via $3.7bn merger deal with former Facebook executive
Eileen Murray had revealed gender discrimination dispute with hedge fund
Veteran activist investor signals he will push for more consolidation in asset management
Truck start-up forces removal of negative videos
Company has shut print magazine to focus on licensing its famous bunny logo
Thirty-six deals worth $5bn-plus unveiled in quarter as bankers race to make up for slowdown from pandemic
Company claims that Trevor Milton personally developed vehicle images ‘in his basement’
EW Scripps to buy ION Media in tie-up with financial support from Berkshire Hathaway
Listing via merger with blank-cheque company values home loan lender at $16bn
$454m deal is latest for US investment group specialising in mid-market businesses
SEC plan to allow managers to keep equity stakes secret is a ‘debilitating blow’, letter says
Genetic sequencing company set to take full ownership of start-up
The truck start-up’s backers say those questioning its technology are missing the point
British billionaire joins fundraising craze in bid to expand Virgin empire
‘We are not trying to sell trucks, we are trying to sell hydrogen,’ says activist investor Jeff Ubben
Ex-Facebook executive Chamath Palihapitiya defends $60m handout after Spac merges with real estate business
US billionaire looks to downsize portfolio as coronavirus pandemic bites
Offer is worth close to double New Jersey-based Immunomedics’ market value
International Edition
